Abstract
N-methyl-N-2-propynyl-1-indanamine, is a new nonhydrazine monoamine oxidase (MAO) inhibitor. It is characterized by a very high potency in vitro as well as by a relatively selective lack of action on liver MAO in vivo. A single s.c. injection of 1.5 mg/kg of Su-11,739 caused significant MAO inhibition for at least 3 weeks in the brain while the liver recovered normal MAO activity after about 1 week. In vivo, Su-11,739 was found to be 15 to 25 times more potent than pargyline and to differ qualitatively from tranylcypromine and iproniazid, principally by its selectivity for MAO of the central nervous system.
Footnotes
- Received November 21, 1966.
- Accepted February 15, 1967.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.